Article

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis

Laboratory of Experimental Oncology, CRS Development of Biomolecular Therapies, SSN Emilia Romagna Istituti Ortopedici Rizzoli IRCCS, Bologna, Italy.
The Journal of clinical investigation (Impact Factor: 13.77). 02/2010; 120(3):668-80. DOI: 10.1172/JCI36667
Source: PubMed

ABSTRACT Ewing sarcoma (EWS) is an aggressive bone tumor of uncertain cellular origin. CD99 is a membrane protein that is expressed in most cases of EWS, although its function in the disease is unknown. Here we have shown that endogenous CD99 expression modulates EWS tumor differentiation and malignancy. We determined that knocking down CD99 expression in human EWS cell lines reduced their ability to form tumors and bone metastases when xenografted into immunodeficient mice and diminished their tumorigenic characteristics in vitro. Further, reduction of CD99 expression resulted in neurite outgrowth and increased expression of beta-III tubulin and markers of neural differentiation. Analysis of a panel of human EWS cells revealed an inverse correlation between CD99 and H-neurofilament expression, as well as an inverse correlation between neural differentiation and oncogenic transformation. As knockdown of CD99 also led to an increase in phosphorylation of ERK1/2, we suggest that the CD99-mediated prevention of neural differentiation of EWS occurs through MAPK pathway modulation. Together, these data indicate a new role for CD99 in preventing neural differentiation of EWS cells and suggest that blockade of CD99 or its downstream molecular pathway may be a new therapeutic approach for EWS.

Download full-text

Full-text

Available from: Mario P Colombo, Jan 18, 2014
0 Followers
 · 
141 Views
  • Source
    • "Recent data suggest that CD99 is not only a marker and therapeutic target for Ewing's sarcoma, but may also contribute to the disease phenotype. Knockdown of CD99 in Ewing's sarcoma cell lines resulted in decreased growth in tissue culture, diminished colony formation in soft agar assays, reduced cell motility, and smaller tumors with less metastasis in xenograft models (Rocchi et al., 2010). This study also suggested that CD99 inhibits full neuronal differentiation by decreasing the activity of the MAP kinase pathway. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tumor development is a complex process resulting from interplay between mutations in oncogenes and tumor suppressors, host susceptibility factors, and cellular context. Great advances have been made by studying rare tumors with unique clinical, genetic, or molecular features. Ewing's sarcoma serves as an excellent paradigm for understanding tumorigenesis because it exhibits some very useful and important characteristics. For example, nearly all cases of Ewing's sarcoma contain the (11;22)(q24;q12) chromosomal translocation that encodes the EWS/FLI oncoprotein. Besides the t(11;22), however, many cases have otherwise simple karyotypes with no other demonstrable abnormalities. Furthermore, it seems that an underlying genetic susceptibility to Ewing's sarcoma, if it exists, must be rare. These two features suggest that EWS/FLI is the primary mutation that drives the development of this tumor. Finally, Ewing's sarcoma is an aggressive tumor that requires aggressive treatment. Thus, improved understanding of the pathogenesis of this tumor will not only be of academic interest, but may also lead to new therapeutic approaches for individuals afflicted with this disease. The purpose of this review is to highlight recent advances in understanding the molecular pathogenesis of Ewing's sarcoma, while considering the questions surrounding this disease that still remain and how this knowledge may be applied to developing new treatments for patients with this highly aggressive disease.
    Oncogene 08/2010; 29(32):4504-16. DOI:10.1038/onc.2010.205 · 8.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We consider a dispersion compensation module (DCM) selection problem for an optical line system in DWDM networks. The objective is to choose DCMs along the equipment of a line system to yield the most desired dispersion map. We present three approaches; (i) integer programming, (ii) dynamic programming, and (iii) a heuristic method. The first two approaches guarantee optimal solutions but may not be scalable either in computing time and/or in memory usage. The third approach often works well in practice though it does not guarantee optimality.
    Telecommunications Network Strategy and Planning Symposium. NETWORKS 2004, 11th International; 07/2004
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Ewing sarcoma family of tumors (ESFT) consists of a group of tumors characterized by morphologically similar round-cell neoplasm and by the presence of a common chromosomal translocation. Although rare, such tumors constitute the third most frequent primary sarcoma of bone after osteosarcoma and chondrosarcoma. ESFT most commonly affects young children and adolescents. Because most patients with clinically apparent localized disease at diagnosis may also have occult metastatic (ie, systemic) disease, multidrug chemotherapy as well as local disease control with surgery and/or radiation therapy are indicated for all patients. Despite marked improvements in survival during the past 40 years for patients with localized disease, lesser improvements have been seen in patients with metastatic or recurrent disease. A better understanding of the complex biology of ESFT may lead to the successful development of biologically targeted therapies. As the regulatory pathways responsible for transformation, growth, and metastasis of ESFT become more refined, the number of potential therapeutic targets will expand.
    The Journal of the American Academy of Orthopaedic Surgeons 02/2010; 18(2):94-107. · 2.40 Impact Factor
Show more